|
|
Volumn 93, Issue 2, 2000, Pages 55-
|
|
Implications of the Relenza ruling
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
SILDENAFIL;
VIRUS SIALIDASE;
ZANAMIVIR;
ASTHMA;
CHRONIC OBSTRUCTIVE LUNG DISEASE;
CLINICAL TRIAL;
COST EFFECTIVENESS ANALYSIS;
DEREGULATION;
DRUG CONTROL;
DRUG INHIBITION;
DRUG MECHANISM;
EDITORIAL;
HEALTH CARE POLICY;
HUMAN;
IMPOTENCE;
INFLUENZA;
INFLUENZA VACCINATION;
INFLUENZA VIRUS;
LICENSING;
MEDICAL SOCIETY;
PRESCRIPTION;
|
|
EID: 0033953001
PISSN: 01410768
EISSN: None
Source Type: Journal
DOI: 10.1177/014107680009300201 Document Type: Editorial |
|
Times cited : (1)
|
|
References (3)
|
